Evidence map›Paper›PMID 42514754›Full record

ReviewPolymers2026

Thermoplastic Post-Consumer Recyclates for Buried Infrastructure: Barriers, Classification Gaps, and a Path Toward Quality-Assured Use.

Anneke Scholz, Ricky Selle, Michael Großhauser

Abstract readReview
In one paragraph

Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anneke ScholzSelle Consult GmbH, Shakespearestraße 52, D-04107 Leipzig, Germany.ORCID 0009-0004-4480-5449
Ricky SelleSelle Consult GmbH, Shakespearestraße 52, D-04107 Leipzig, Germany.
Michael GroßhauserFraunhofer Institute for Structural Durability and System Reliability LBF, Schlossgartenstraße 6, D-64289 Darmstadt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the Green Deal and the Circular Economy Action Plan, the European Union aims to replace half of the fossil-based raw materials in plastics with sustainable alternatives by 2030. In the plastic pipe industry, the use of post-consumer recyclates (PCRs) remains very limited due to reduced material quality, economic hurdles, limited availability, non-specific classification requirements, and a lack of testing standards. This paper presents two interconnected contributions to the quality-assured use of PCR for buried utility infrastructure made from Polyethylene (PE), Polypropylene (PP), and unplasticized Polyvinyl Chloride (PVC-U). First, a methodological framework, based on EN 13476, defines suitability as the intersection of material classification and application-specific requirements profile. A review of the current regulatory and technical situation reveals a systemic discrepancy: requirements profiles are oriented toward virgin material, while the scope of classification for PCR remains insufficiently defined. As a result, PCR is either used without adequate suitability assessment or blended with fillers, thereby limiting recyclability. Secondly, the review focuses on additive strategies, including restabilization, compatibilization, chain modification, and recyclate-compatible functional additives. These strategies are among the main technical solutions for closing the gap between PCR properties and the product's requirements, reducing filler dependency, and enabling the long-term use of PCR in safety-critical applications.

Indexed as

accelerated agingburied infrastructuredurability assessmentlong-term propertiesmaterial classificationnon-pressure pipe systemspost-consumer recyclaterecycled polyolefins

Identifiers

PMID42514754
PMCPMC13419143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.